Takeda Reported Talking With Cipla, Lupin For India Acquisition
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical reportedly has been holding takeover talks with Cipla, India's second-largest drug maker, and Lupin, fifth largest, according to sources